Infervision, a Chinese startup that offers artificial intelligence (AI)-based medical imaging solutions, has closed a new investment that brings the firm’s total capital raise in its Series D round to nearly 900 million yuan ($139 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
